Literature DB >> 8260304

Fentanyl inhibits the uptake of [3H]noradrenaline in cultured neuronal cells.

R Atcheson1, D J Rowbotham, D G Lambert.   

Abstract

We have examined how fentanyl modulates [3H]noradrenaline uptake in two cultured neuronal cell preparations, the human neuroblastoma SH-SY5Y and the rat phaeochromocytoma PC12. Fentanyl produced a significant, dose-dependent inhibition of [3H]noradrenaline uptake at concentrations in excess of 0.1 mumol litre-1 (P < 0.05) and 0.3 mumol litre-1 (P < 0.05) for PC12 and SH-SY5Y cells, respectively. However, these values exceed the serum concentration of fentanyl required to produce analgesia. At the maximum concentration examined (100 mumol litre-1), fentanyl produced 85-95% inhibition of uptake. This effect was not antagonized by naloxone, implying a nonopioid mechanism of action. Imipramine 1 mumol litre-1 reduced [3H]noradrenaline uptake by 65-70% but morphine, in contrast to fentanyl, had no effect (P > 0.1).

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8260304     DOI: 10.1093/bja/71.4.540

Source DB:  PubMed          Journal:  Br J Anaesth        ISSN: 0007-0912            Impact factor:   9.166


  4 in total

Review 1.  Transdermal fentanyl. A review of its pharmacological properties and therapeutic efficacy in pain control.

Authors:  W Jeal; P Benfield
Journal:  Drugs       Date:  1997-01       Impact factor: 9.546

2.  Opioid receptor gene expression in human neuroblastoma SH-SY5Y cells following tapentadol exposure.

Authors:  Francesca Felicia Caputi; Donatella Carretta; Thomas M Tzschentke; Sanzio Candeletti; Patrizia Romualdi
Journal:  J Mol Neurosci       Date:  2014-02-04       Impact factor: 3.444

3.  Studies on the mechanism of [3H]-noradrenaline release from SH-SY5Y cells: the role of Ca2+ and cyclic AMP.

Authors:  R Atcheson; D G Lambert; R A Hirst; D J Rowbotham
Journal:  Br J Pharmacol       Date:  1994-03       Impact factor: 8.739

Review 4.  Noradrenergic Mechanisms in Fentanyl-Mediated Rapid Death Explain Failure of Naloxone in the Opioid Crisis.

Authors:  Randy Torralva; Aaron Janowsky
Journal:  J Pharmacol Exp Ther       Date:  2019-09-06       Impact factor: 4.030

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.